深度学习对宫癌剂量预测模型的比较研究 卷度调制弧形疗法
Zhe Wu1,2, Mujun Liu1, Ya Pang2
1Department of Digital Medicine, School of Biomedical Engineering and Medical Imaging, Army Medical University (Third Military Medical University), Chongqing, China.
Technology in cancer research & treatment
|April 8, 2024
概括
深度学习模型准确地预测宫癌的辐射剂量 VMAT. 3D U-Net 模型在预测 voxel 级剂量分布方面表现最好.
科学领域:
- 医学物理 医学物理
- 放射治疗瘤学 放射治疗瘤学
- 人工智能在医学中的应用
背景情况:
- 深度学习 (DL) 在放射瘤学中越来越多地用于剂量预测.
- 缺乏对不同DL技术的比较研究,阻碍了临床采用.
- 准确的剂量预测对于优化宫癌治疗中的体积调制弧线疗法 (VMAT) 至关重要.
研究的目的:
- 为了比较四个最先进的深度学习模型的性能.
- 为了评估它们在预测子宫癌的伏塞尔水平剂量分布方面的准确性,VMAT.
- 为了确定这个应用程序最有效的DL模型.
主要方法:
- 对261名宫癌患者计划的回顾性分析.
- 利用3D U-Net和三个变体,在CT图像,PTV和OAR面具上进行训练.
- 在测试组中使用平均绝对误差 (MAE),剂量差异,剂量指数和滴滴相似系数 (DSC) 评估模型.
主要成果:
- 所有DL模型都显示出有希望的剂量预测准确性,在PTV范围内最大MAE为0.83% (UNETR).
- 风险器官 (OARs) 的最大MAE在左腿部头部 (6.95%) 观察到.
- 3D U-Net实现了全身的最低MAE (0.94%),优于其他模型.
结论:
- 深度学习模型准确地预测子宫癌的voxel级剂量分布 VMAT.
- 虽然模型表现出类似的性能,但3D U-Net在整体体剂量预测方面表现出卓越的结果.
- 这些先进的DL模型具有在宫癌VMAT中临床应用的巨大潜力.
更多相关视频
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.8K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.8K
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
